NO20055136L - Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer - Google Patents

Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer

Info

Publication number
NO20055136L
NO20055136L NO20055136A NO20055136A NO20055136L NO 20055136 L NO20055136 L NO 20055136L NO 20055136 A NO20055136 A NO 20055136A NO 20055136 A NO20055136 A NO 20055136A NO 20055136 L NO20055136 L NO 20055136L
Authority
NO
Norway
Prior art keywords
immunosuppressant
treatment
pharmaceutical composition
skin disorders
combinations
Prior art date
Application number
NO20055136A
Other languages
English (en)
Other versions
NO20055136D0 (no
Inventor
Stefan Hirsch
Friedrich Karl Mayer
Nabila Sekkat
Carle Paul
Carl-Martin Weiss
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055136D0 publication Critical patent/NO20055136D0/no
Publication of NO20055136L publication Critical patent/NO20055136L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives synergistiske kombinasjoner av en makrolid T-celle immunomodulator eller -immunosuppresant som 33-epiklor-33-desoksyaskomycin og et mykningsmiddel som dimetikon, glyserol eller isostearyl isostearat. Kombinasjonene er anvendelig særlig for behandling av dermatologiske eller mykosale sykdommer som tørr hud eller atopisk eller kontaktdermatitt.
NO20055136A 2003-04-04 2005-11-02 Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer NO20055136L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307866.4A GB0307866D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003513 WO2004087141A1 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases

Publications (2)

Publication Number Publication Date
NO20055136D0 NO20055136D0 (no) 2005-11-02
NO20055136L true NO20055136L (no) 2006-01-04

Family

ID=9956229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055136A NO20055136L (no) 2003-04-04 2005-11-02 Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer

Country Status (13)

Country Link
US (1) US20070276004A1 (no)
EP (1) EP1613314A1 (no)
JP (1) JP2006522059A (no)
CN (1) CN1767826A (no)
AU (1) AU2004226821A1 (no)
BR (1) BRPI0409187A (no)
CA (1) CA2521250A1 (no)
GB (1) GB0307866D0 (no)
IS (1) IS8105A (no)
MX (2) MXPA05010703A (no)
NO (1) NO20055136L (no)
RS (1) RS20050739A (no)
WO (1) WO2004087141A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US8010209B2 (en) 2005-10-14 2011-08-30 Nanostim, Inc. Delivery system for implantable biostimulator
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
US8543205B2 (en) 2010-10-12 2013-09-24 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
JP2013540022A (ja) 2010-10-13 2013-10-31 ナノスティム・インコーポレイテッド スクリュー戻り回転防止要素を備えたリードレス心臓ペースメーカ
CN103429296A (zh) 2010-12-13 2013-12-04 内诺斯蒂姆股份有限公司 递送导管系统和方法
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
WO2012088118A1 (en) 2010-12-20 2012-06-28 Nanostim, Inc. Leadless pacemaker with radial fixation mechanism
AU2012223256A1 (en) * 2011-03-03 2013-09-19 Allergan, Inc. Silicone-based ophthalmic formulations
WO2013067496A2 (en) 2011-11-04 2013-05-10 Nanostim, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
US9802054B2 (en) 2012-08-01 2017-10-31 Pacesetter, Inc. Biostimulator circuit with flying cell
US20180071190A1 (en) * 2015-03-25 2018-03-15 Gct Gmbh Cosmetic product and concentrate for producing the cosmetic product
RU2741504C2 (ru) * 2016-04-04 2021-01-26 Драг Деливери Солюшнз Лимитед Композиция для местного применения, включающая такролимус
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
WO2023114680A1 (en) * 2021-12-16 2023-06-22 The Procter & Gamble Company Hair conditioning composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
EP0786986B1 (en) * 1994-10-26 2002-03-20 Novartis AG Use of an unsaturated fatty alcohol
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
CA2213989C (en) * 1995-12-28 2007-05-29 Yoshitomi Pharmaceutical Industries Ltd. External preparation for topical administration
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
US6423323B2 (en) * 1997-08-18 2002-07-23 Stephanie Neubourg Foam skin cream, uses of the foam skin protection cream and a process for its preparation
ATE464900T1 (de) * 1998-03-26 2010-05-15 Astellas Pharma Inc Retardpräparat mit makroliden wie tacrolimus
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
JP2001064164A (ja) * 1999-06-23 2001-03-13 Health Science Center:Kk 止痒皮膚塗布剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20070276004A1 (en) 2007-11-29
BRPI0409187A (pt) 2006-04-11
NO20055136D0 (no) 2005-11-02
EP1613314A1 (en) 2006-01-11
RS20050739A (en) 2007-11-15
AU2004226821A1 (en) 2004-10-14
GB0307866D0 (en) 2003-05-14
JP2006522059A (ja) 2006-09-28
WO2004087141A1 (en) 2004-10-14
MXPA05010703A (es) 2005-12-12
CN1767826A (zh) 2006-05-03
MXPA05010708A (es) 2005-12-12
IS8105A (is) 2005-10-31
WO2004087141B1 (en) 2005-01-06
CA2521250A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
NO20055136L (no) Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
NO20065195L (no) Terapeutiske enzymformuleringer og anvendelser derav
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
WO2010070675A3 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
TW200801031A (en) Steroid nitrooxyderivatives
EP1663959A4 (en) NEW AMIDINE COMPOUNDS FOR THE TREATMENT OF MICROBIAL INFECTIONS
WO2006018454A3 (de) Kosmetische zubereitung mit hyaluronsäure und saponinen zur behandlung von hautalterungserscheinungen
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
NO20053903L (no) Nukleotidlipidesterderivater.
BRPI0412989A (pt) combinação farmacêutica útil para mobilização de célula-tronco
WO2005060960A3 (en) Use of histamine to treat bone disease
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
WO2008050157A3 (en) Ozonated oil formulations
WO2004075867A3 (de) Zubereitungen eines extraktes von eperua falcata und/oder dessen inhaltstoffe enthaltend
WO2007064859A3 (en) Compound and method for suppressing retroviral replication
NO20055137L (no) Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application